Stay up-to-date with all of the life science events taking place in the Greater Boston area with the Science in Boston events calendar! From academia to industry and biotech to pharma, our events calendar is your complete source for life science conferences, symposiums, networking, and workshops in Boston. We even cover science pub nights and science fundraisers!
If you’re interested in promoting your life science event on the Science in Boston events calendar, please use our event submission form.
- This event has passed.
Biomedical Informatics Entrepreneurs Salon: Iris Grossman, ElevenTx
January 26, 2023Free
Hosted by Harvard Office of Technology Development and the HMS Dept. of Biomedical Informatics. Open to all.
Iris Grossman, Ph.D., Chief Therapeutics Officer of Eleven Therapeutics
We are pleased to return, at last, to in-person Salon events and intend to host this talk as a hybrid event. To attend this talk in person, Harvard ID is required. Non-Harvard affiliates, we truly welcome and invite you to join us on Zoom (access the Zoom registration link via Eventbrite’s “Online Event Page” after registering with Eventbrite). For in-person attendees, the location is the Countway Library, room 102, at Harvard Medical School in Boston, and a reception will be provided! However you plan to join us, please do register with Eventbrite.
On the leading edge of Personalized Medicine, Big Data Analytics and BioPharmaceutical R&D for ~20 years, Iris is the Chief Therapeutics Officer of Eleven Therapeutics, where she oversees the strategy and development of novel RNA-based therapeutics discovered by the company’s platform, which uniquely marries between combinatorial chemistry and A.I. to decipher the structure-activity relationship of durable, effective and safe respiratory and metabolic therapeutics. Prior to joining Eleven, Iris served in Chief Scientific Officer roles (CAMP4, Amide Technologies (acting)) and consulted for top VCs in the Boston area. Prior to that, Iris held leadership positions in, or consulted for top Big Pharma (GSK, Eli Lily, Takeda and Teva – where she was VP, Head of Early-Stage Development). She specializes in leveraging multi-dimensional genomic insights and eHealth as engines of therapeutic discovery, development and lifecycle management across a wide range of modalities and therapeutic areas. Iris serves as chairman of the SAB at BC Platforms, and as Strategic Scientific Advisor at Modulight.bi, and CGRP Diagnostics. Dr. Grossman earned her B.Sc. in medicine at the Technion, and a Ph.D. in medicine, population genomics and pharmacogenetics from the Technion, co-mentored with the Weizmann Institute. Her post-doc fellowship in Personalized Medicine and Population Genomics was completed at Duke university.